skip to main content
European Commission Logo
en English
Newsroom

Support to the evaluation of the Drug Precursors Regulations

The objective of the study is to provide the European Commission with the necessary information and analysis to support its evaluation of Regulation (EC) No 273/2004 on drug precursors and Regulation (EC) No 111/2005 on trade in drug precursors between the EU and third countries.

Deadline:  25/09/2017

TED Linketendering.ted.europa.eu/cft/cft-display...

See alsoContract notice

  • Number: 639/PP/GRO/IMA/17/1133/9952

The results will contribute to a report on the implementation and functioning of the regulations on drug precursors. The Commission must submit this report to the European Parliament and the Council of the European Union by 31 December 2019. 

During the study, the following 5 tasks must be carried out in line with Better Regulation principles:

  • Task 1 - Establishing evaluation methodology
  • Task 2 - Providing information on the implementation of the regulations, while assessing their effectiveness, efficiency, coherence, relevance and EU added value
  • Task 3 - Assessing the need for additional action to monitor and control suspicious transactions with non-scheduled substances
  • Task 4 - A stakeholders' consultation and an open public consultation
  • Task 5 - A validation workshop

Important

Please note that all our tendering documents are published through the Commission-wide 'eTendering' platform.

If you are interested in this call, please download the tender documents from the platform.

The documents are always publicly visible and downloadable. To register for the call, simply add your e-mail address and create a password. You will be able to ask questions and you will be automatically notified about any changes that may be published (additional documents, answers to questions...).